Medically reviewed by Drugs.com. Last updated on Sep 7, 2022.
Warning: Serious Infusion-related Reactions and NeurotoxicitySerious Infusion-related Reactions: Naxitamab-gqgk can cause serious infusion reactions, including cardiac arrest, anaphylaxis, hypotension, bronchospasm, and stridor. Premedicate prior to each naxitamab-gqgk infusion as recommended. Reduce the rate, interrupt infusion, or permanently discontinue naxitamab-gqgk based on severity.Neurotoxicity: Naxitamab-gqgk can cause severe neurotoxicity, including severe neuropathic pain, transverse myelitis, and reversible posterior leukoencephalopathy syndrome (RPLS). Premedicate to treat neuropathic pain as recommended. Permanently discontinue naxitamab-gqgk based on the adverse reaction and severity .
Commonly used brand name(s)
In the U.S.
Available Dosage Forms:
Therapeutic Class: Antineoplastic Agent
Pharmacologic Class: Naxitamab
Uses for naxitamab-gqgk
Naxitamab-gqgk injection is used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), to treat relapsed (has come back) or refractory (did not respond to previous treatment) high-risk neuroblastoma (a type of cancer that most often occurs in young children) in the bone or bone marrow in patients who have shown a partial response, a minor response, or have stable disease to previous treatment. Naxitamab-gqgk is a GD2-binding monoclonal antibody.
Naxitamab-gqgk is to be given only by or under the direct supervision of your doctor.
Before using naxitamab-gqgk
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For naxitamab-gqgk, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to naxitamab-gqgk or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of naxitamab-gqgk injection in children younger than 1 year of age. Safety and efficacy have not been established.
Appropriate studies have not been performed on the relationship of age to the effects of naxitamab-gqgk injection in the geriatric population. Safety and efficacy have not been established.
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Interactions with food/tobacco/alcohol
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other medical problems
The presence of other medical problems may affect the use of naxitamab-gqgk. Make sure you tell your doctor if you have any other medical problems, especially:
- Eye problems or
- Peripheral neuropathy (nerve problem) or
- Spinal cord problems (eg, transverse myelitis) or
- Urinary retention (problem urinating or emptying the bladder)—Use with caution. May make these conditions worse.
- Hypertension (high blood pressure), uncontrolled—Should not be used in patients with this condition.
Proper use of naxitamab-gqgk
A nurse or other trained health professional will give you naxitamab-gqgk in a hospital. Naxitamab-gqgk is given through a needle placed in one of your veins.
Naxitamab-gqgk must be given slowly, so the needle will remain in place for 30 to 60 minutes. It is given on Days 1, 3, and 5 of each treatment cycle, which is usually repeated every 4 or 8 weeks. Your doctor will tell you how many treatment cycles you need. You may also receive medicines to help prevent possible allergic reactions, pain, nausea, or vomiting to the injection.
Naxitamab-gqgk needs to be given on a fixed schedule. If you miss a dose, call your doctor, home health caregiver, or treatment clinic for instructions.
Precautions while using naxitamab-gqgk
Your doctor will check your progress closely while you are receiving naxitamab-gqgk. This will allow your doctor to see if the medicine is working properly and to decide if you or your child should continue to receive it. Blood and urine tests may be needed to check for unwanted effects.
Using naxitamab-gqgk while you are pregnant can harm your unborn baby. If you are a woman who can get pregnant, your doctor may do tests to make sure you are not pregnant before starting treatment. Use an effective form of birth control to keep from getting pregnant during treatment and for at least 2 months after the last dose of naxitamab-gqgk. If you think you have become pregnant while using the medicine, tell your doctor right away.
Naxitamab-gqgk may cause a rare but serious type of an allergic reaction called an infusion reaction, which can be life-threatening and require immediate medical attention. Tell your doctor right away if you or your child start to have cough, trouble breathing, hives, itching, skin rash, lightheadedness, dizziness, or fainting, tightness in the chest, or swelling of the face, eyes, lips, mouth, or tongue.
Naxitamab-gqgk may cause nerve pain (eg, pain in the stomach, bone, neck, legs, or arms). Tell your doctor right away if the pain becomes severe.
Naxitamab-gqgk may cause transverse myelitis (swelling of the spinal cord). Check with your doctor right away if you or your child have back, leg, or stomach pain, muscle weakness in the arms or legs, or bladder and bowel problems.
Naxitamab-gqgk may cause reversible posterior leukoencephalopathy syndrome (RPLS). Tell your doctor if you have severe headache, changes in vision, fast, pounding, or uneven heartbeat, seizures, unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness.
Naxitamab-gqgk may cause peripheral neuropathy. Check with your doctor right away if you or your child are having burning, numbness, tingling, or painful sensations in the arms, hands, legs, or feet.
Check with your doctor immediately if blurred vision, difficulty in reading, or any other change in vision occurs during or after treatment. Your doctor may want you or your child to have your eyes checked by an ophthalmologist (eye doctor).
Naxitamab-gqgk may cause bladder problems (eg, prolonged urinary retention). Check with your doctor right away if you or your child have decreased in urine volume, decreased in frequency of urination, difficulty in passing urine, or painful urination.
Naxitamab-gqgk may cause hypertension (high blood pressure). Check with your doctor right away if you or your child have blurred vision, dizziness, nervousness, headache, pounding in the ears, or slow or fast heartbeat.
Naxitamab-gqgk side effects
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
- Back pain, sudden and severe
- bigger, dilated, or enlarged pupils (black part of eye)
- blurred vision
- bone pain
- burning, numbness, tingling, or painful sensations
- change in color vision
- chest tightness
- decrease in frequency of urination
- decrease in urine volume
- difficulty in passing urine
- difficulty seeing at night
- increased sensitivity of the eyes to light
- muscle weakness, sudden and progressing
- nausea and vomiting
- painful urination
- pounding in the ears
- slow or fast heartbeat
- stomach pain
- trouble breathing
- unsteadiness or awkwardness
- unusual tiredness or weakness
- weakness in the arms, hands, legs, or feet
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Blistering, peeling, loosening of the skin
- decreased appetite
- fast heartbeat
- flushing, redness of the skin
- increased sweating
- joint or muscle pain
- red, irritated eyes
- runny nose
- sore throat
- sores, ulcers, or white spots in the mouth or on the lips
- unusual drowsiness, dullness, tiredness, weakness or feeling of sluggishness
- unusually warm skin
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
More about naxitamab
- Check interactions
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.